iCAD Secures Chinese Regulatory Approval for Digital Mammography CAD Technology

iCAD, Inc. ICAD announces that it has secured regulatory approval for its SecondLook® Digital by the State Food and Drug Administration in the People's Republic of China. The approval allows iCAD's SecondLook Digital computer-aided detection technology to be sold with GE Digital Mammography Systems in order to assist radiologists in distinguishing potential cancers from other anomalies on a mammogram.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsFDAHealth CareHealth Care Technology
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!